OpenVSafe by OpenVAERS
Search V-safe

BLY-32142-75361

3 vaccinations 8 coded responses 41 check-ins 8 free-text entries 0 call cases
Sex
Male
Age at first dose
46-50
ZIP prefix
982 / WA
Registered
2021-04-20
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-20
    Registered in v-safe
  2. 2021-04-20
    Dose 1 — Moderna
  3. 2021-04-20
    Health check-in — day 0, dose 1
    Feeling: Poor · Site: Itching · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  4. 2021-04-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-04-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-04-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-04-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-04-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-27
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-05-05
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-05-11
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-05-18
    Dose 2 — Moderna
  14. 2021-05-18
    Survey response — day 0, dose 2
    MedDRA: Brain fog — Feeling: Poor · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Brain fog
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-05-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  16. 2021-05-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · None
    Adult check-in
  17. 2021-05-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-05-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-05-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  20. 2021-05-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-05-25
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  22. 2021-06-01
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-06-08
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-06-15
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-06-23
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-06-29
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-08-17
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-11-16
    Survey response — 6 months, dose 2
    MedDRA: Exposure to SARS-CoV-2, Productive cough, Secretion discharge — Feeling: Good
    Free text: Mucous coughs; extremely more frequently than before COVID-19 exposure & didn't start until after.
    MedDRA releases: 2024-11 · check-in free text available
  29. 2021-11-22
    Dose 3 — Moderna
  30. 2021-11-22
    Health check-in — day 0, dose 3
    Feeling: Good · None
    Adult check-in
  31. 2021-11-23
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  32. 2021-11-24
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  33. 2021-11-25
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  34. 2021-11-26
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  35. 2021-11-27
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  36. 2021-11-28
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  37. 2021-11-29
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  38. 2021-12-06
    Survey response — day 14, dose 3
    MedDRA: Cough, Discomfort, Increased upper airway secretion, Respiratory tract congestion — Feeling: Good
    Free text: Hyper mucous secretion from throat/lungs. Discomfort from congestion with cough. No fever, no headache, no fatigue. Persistent cough.
    MedDRA releases: 2024-11 · check-in free text available
  39. 2021-12-13
    Survey response — day 21, dose 3
    MedDRA: Productive cough, Secretion discharge — Feeling: Good
    Free text: Excessive mucous in bronchial tubes causing frequent productive coughs.
    MedDRA releases: 2024-11 · check-in free text available
  40. 2021-12-20
    Survey response — day 28, dose 3
    MedDRA: Cough, Lower respiratory tract congestion — Feeling: Good
    Free text: Persistent cough and excessive mucous in bronchial tubes.
    MedDRA releases: 2024-11 · check-in free text available
  41. 2021-12-27
    Survey response — day 35, dose 3
    MedDRA: Cough, Secretion discharge — Feeling: Good
    Free text: Persistent excessive mucous that causes coughs from bronchial tubes.
    MedDRA releases: 2024-11 · check-in free text available
  42. 2022-01-03
    Survey response — day 42, dose 3
    MedDRA: Productive cough, Secretion discharge — Feeling: Good
    Free text: Persistent excessive mucous causing productive coughs.
    MedDRA releases: 2024-11 · check-in free text available
  43. 2022-02-21
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  44. 2022-05-24
    Survey response — 6 months, dose 3
    MedDRA: Cough, Productive cough — Feeling: Good
    Free text: Persistent mucous cough.
    MedDRA releases: 2024-11 · check-in free text available
  45. 2022-11-22
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-20Moderna
22021-05-18Moderna
32021-11-22Moderna No

Free text

Release 8 — day 0, dose 2

2021-05-18

Systemic reaction (other): Brain fog

Release 10 — 6 months, dose 2

2021-11-16

Symptoms: Mucous coughs; extremely more frequently than before COVID-19 exposure & didn't start until after.

Release 10 — day 14, dose 3

2021-12-06

Symptoms: Hyper mucous secretion from throat/lungs. Discomfort from congestion with cough. No fever, no headache, no fatigue. Persistent cough.

Release 10 — day 21, dose 3

2021-12-13

Symptoms: Excessive mucous in bronchial tubes causing frequent productive coughs.

Release 10 — day 28, dose 3

2021-12-20

Symptoms: Persistent cough and excessive mucous in bronchial tubes.

Release 10 — day 35, dose 3

2021-12-27

Symptoms: Persistent excessive mucous that causes coughs from bronchial tubes.

Release 10 — day 42, dose 3

2022-01-03

Symptoms: Persistent excessive mucous causing productive coughs.

Release 11 — 6 months, dose 3

2022-05-24

Symptoms: Persistent mucous cough.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDDiscomfort · · ✓
SDExposure to SARS-CoV-2 · · ✓
SDIncreased upper airway secretion · · ✓
SDLower respiratory tract congestion · · ✓
SDProductive cough · · ✓
SDRespiratory tract congestion · · ✓
SDSecretion discharge · · ✓
SROBrain fog ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release